BIOMUNE SYSTEMS INC
8-K, 1998-06-19
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: INTERNATIONAL LEASE FINANCE CORP, 8-K, 1998-06-19
Next: CALIFORNIA MUNI FUND, PREC14A, 1998-06-19



                    SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549
                                    
                                 FORM 8-K


                              CURRENT REPORT
     
                  PURSUANT TO SECTION 13 OR 15(d) OF THE
                     SECURITIES EXCHANGE ACT OF 1934


                       Date of Report: June 19, 1998
                                   


                            BIOMUNE SYSTEMS, INC.
           (Exact name of registrant as specified in its charter)



Commission File Number:  0-11472 
                                   
     Nevada                                             87-0380088
(State of Incorporation)                   (I.R.S. Employer Identification No.)


            2401 South Foothill Drive, Salt Lake City, UT  84109
                (Address of principal executive offices)(Zip Code)


Registrant's telephone number, including area code:(801) 466-3441

<PAGE>

ITEM 2.  Acquisition or Disposition of Assets.

On June 1, 1998, Biomune Systems, Inc. (the "Company" or the "Registrant") 
signed an agreement to purchase a 52 percent ownership interest in Rockwood 
Companies, LLC, formerly Rockwood Vitamins, LLC, a California limited 
liability company ("Rockwood").  Final issues surrounding the closing of the 
transaction were resolved on June 19, 1998.  Rockwood is the successor in 
interest of Rockwood Cosmetics, Inc., a California corporation.  Prior to the 
acquisition of the controlling interest in Rockwood, the sole owner of 
Rockwood was Cypress Springs LLC, a California limited liability company 
controlled by Ira E. Ritter.  Mr. Ritter briefly served as the President of 
the Registrant in 1997.  The purchase price for the controlling interest of 
Rockwood is $3,360,000, payable in a combination of cash, stock and a 
promissory note.  The cash includes sums previously paid to Mr. Ritter under 
an earlier transaction that was terminated by the parties in January 1998.  
$610,000 has been paid in cash and $1,750,000 will be paid pursuant to a 
promissory note between the date of closing and August 31, 1999.  The first 
payment of $250,000 under the note was made on June 15, 1998.  Quarterly 
payments are due until the final payment on or before August 31, 1999.  The 
note is secured by the 52 percent interest being purchased by the Company and 
is personally guaranteed by David Derrick, a shareholder of the Company and 
its former President and Chairman.

In addition, the Registrant will issue 1,000,000 shares of a newly authorized 
series of Preferred Stock (the "Series G Preferred").  The Series G Preferred 
will be issued in blocks of 250,000 shares, when, as and if Rockwood generates 
profits of at least $250,000 for a calendar quarter, provided, however, that 
no shares will be issued after March 31, 2000.

Also as a part of the transaction, the Company has extended a $1,000,000 
operating line of credit to Rockwood, of which $800,000 has been funded.  The 
line of credit is secured by all assets, including accounts receivable and 
inventory, of Rockwood.  Outstanding balances on the line of credit bear 
interest at the prime rate plus one percent and interest is payable monthly.  
The line of credit has a one-year term and is renewable for up to two years, 
with a payment of 1.5% of the amount outstanding at the time of renewal as a 
renewal fee.

Rockwood is managed by Mr. Ritter as its President under the terms of a 
written management agreement with Andela Group, Inc. ("Andela"), a company 
owned and controlled by Mr. Ritter.  Under the terms of that agreement, 
(through Andela) Mr. Ritter receives a fee of $200,000 per year and may earn a 
bonus equal to 20 percent of net profits in excess of $1,000,000.  Mr. 
Ritter's actions are subject to review of a "board of directors" of Rockwood, 
comprised of two persons appointed by the Company and one person appointed by 
Cypress Springs, LLC.  The board currently consists of Mr. Ritter, Mr. Derrick 
and Michael G. Acton, an officer and director of the Company.

Funds for the purchase of the Rockwood interest will be provided to the 
Company through debt and through the sale of the Company's securities.  Mr. 
Derrick has agreed to purchase approximately $2,000,000 of the Company's 
previously authorized Series F Preferred Stock.  In addition, the Company 
entered into a line of credit agreement with a family trust pursuant to which 
it may borrow up to $600,000 at prime plus one percent.  Approximately 
$300,000 has been borrowed to date under this line of credit.  The line of 
credit is secured by common stock of the Company and is personally guaranteed 
by Mr. Derrick.  The trustee of the line of credit is Mr. Acton's brother.

ITEM 4.   Changes in Registrant's Certifying Accountant.

On June 15, 1998, the Company appointed Tanner + Co. ("Tanner") to replace 
Arthur Andersen LLP ("Andersen") as independent auditors of the Company.

The report of Andersen on the Company's consolidated financial statements for 
the years ended September 30, 1997 and 1996 contained no adverse opinion or 
disclaimer of opinion and was not qualified or modified as to uncertainty, 
audit scope or accounting principle, except that such report on the 
consolidated financial statements included an explanatory paragraph with 
respect to the Company being in the development stage and its having suffered 
recurring losses which raise substantial doubt about its ability to continue 
as a going concern. 

The decision to engage Tanner as the Company's independent auditors was 
approved by the Company's board of directors.

In connection with the audits for the years ended September 30, 1997 and 1996, 
and through June 11, 1998, the Company has had no disagreements with Andersen 
on any matter of accounting principles or practices, financial statement 
disclosure, or auditing scope or procedure, which disagreements if not 
resolved to the satisfaction of Andersen would have caused it to make 
reference thereto in its report on the consolidated financial statements for 
1997 and 1996.

During the course of Andersen's review of the consolidated financial 
statements of the Company for the quarter ended March 31, 1998, certain 
matters came to Andersen's attention that were reported to the Audit Committee 
of the Company in a letter dated May 14, 1998.  Andersen informed the Audit 
Committee that with respect to certain related-party notes receivable and 
trade accounts receivable significant collections had not been received to 
date.   Additionally, Andersen informed the Audit Committee that with respect 
to certain of the Company's nutraceutical inventories there had been minimal 
sales activity.  Andersen informed the Audit Committee that management's 
assessment was that both the receivables and the inventory balances were fully 
realizable and no additional reserves were necessary.  Andersen encouraged the 
Audit Committee to monitor these issues with management.

Substantive audit tests and further investigation into these issues would have 
been a necessary part of Andersen's audit procedures for the fiscal year-end 
September 30, 1998 financial statements had the client/auditor relationship 
not terminated.  Andersen has been authorized by the Company to respond to any 
and all inquiries by the successor auditors, without limitation.  The Company 
has indicated it will cooperate fully with the new auditors to address these 
matters and these matters had no bearing on the decision to change auditors.

Andersen has provided to the Company a letter addressed to the Securities and 
Exchange Commission stating that it has reviewed the disclosure provided in 
this Current Report and has no disagreement with the relevant portions of this 
disclosure, pursuant to the requirements of Item 304(a)(3) of Regulation S-B.  
A copy of such letter, dated as of June 19, 1998, is filed as Exhibit 16 to 
this Current Report on Form 8-K.

During the years ended September 30, 1997 and 1996, and through June 15, 1998, 
there have been no other reportable events (as referenced in Item 
304(a)(1)(iv) of Regulation S-B).

ITEM 5. Other Events.

At the time of the closing of the Rockwood transaction described above, David 
G. Derrick resigned as an executive officer and director of the Company.  Mr. 
Derrick had previously served as President, Chief Executive Officer and 
Chairman of the Board of Directors of the Company.  Upon acceptance of Mr. 
Derrick's resignation, the Board of Directors appointed Michael G. Acton to 
succeed Derrick as President and Chief Executive Officer of the Company and to 
serve as a member of the Board of Directors to fill the vacancy created by Mr. 
Derrick's resignation.  The Board also appointed one of its members, 
Christopher D. Illick, as Chairman of the Board.

ITEM 7.  Financial Statements and Exhibits.

     (a) Financial Statements of Business Acquired.  The audited financial 
statements of Rockwood will be filed by amendment to this Report within 60 
days.

     (b) Pro Forma Financial Information.  Pro forma financial information will
be filed by amendment to this Report.

     (c) Exhibits

     10 Purchase Agreement between Biomune Systems, Inc. and Cypress Springs 
LLC. (with exhibits)

     16 Letter regarding change in certifying accountant



<PAGE>
                                SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.

                              BIOMUNE SYSTEMS, INC.
                              (Registrant)

                                   /s/ Michael G. Acton
                              By: ___________________________
Date: June 19, 1998               Michael G. Acton
                                  Chief Executive Officer






























[Arthur Andersen Letterhead]


June 19, 1998

Office of the Chief Accountant
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549


Dear Sir/Madam:

We have read Item 4 included in the Form 8-K dated June 19, 1998 of Biomune 
Systems, Inc. and subsidiaries to be filed with the Securities and Exchange 
Commission and are in agreement withthe statements contained therein.

Very truly yours,

ARTHUR ANDERSEN LLP


By /s/ Kent M. Bowman


                           PURCHASE AGREEMENT

     PURCHASE AGREEMENT, dated as of May 27, 1998 (the "Agreement"), by and 
between  CYPRESS SPRINGS LLC, a California limited liability company 
("Cypress") managed by Ira E. Ritter, an individual residing in California 
("Ritter"), and BIOMUNE SYSTEMS, INC., a Nevada corporation ("Biomune").

                               RECITALS

     A.     Cypress is the sole owner of all of the issued and outstanding 
member interests of Rockwood Companies, LLC, a California limited liability 
company ("Rockwood") formerly known as Rockwood Investments, Inc., d.b.a. 
Rockwood Cosmetics, Inc. ("Cosmetics"), which is in the business of marketing 
and distributing vitamin, nutrition and personal care products, including the 
products formerly marketed through Cosmetics and Rockwood Vitamins LLC 
("Vitamins").

     B.     Biomune is a Nevada corporation engaged in the business of 
researching, developing and selling pharmaceutical and nutraceutical products 
based on a patented whey protein technology.  In July 1997, Biomune entered 
into an agreement with Ritter to acquire Cosmetics and pursuant to that 
agreement Biomune made option and other payments to Ritter and Cosmetics 
totaling $360,000 toward the purchase price of Cosmetics.  That agreement was 
terminated by Biomune in January 1998.

     C.     Pursuant to this Agreement herein, Biomune intends to purchase a 
controlling interest in Rockwood from Cypress as contemplated herein. 

     D.     Upon completion of the transactions contemplated herein, the 
parties desire to have Rockwood owned 52% by Biomune and 48% by Cypress.

     E.     It is intended herewith that prior to the closing Ritter has or 
will make a capital contribution to Rockwood of all of the assets and business 
interests of Vitamins and any related business interests, including royalty 
agreements, license agreements, marketing or consulting agreements pursuant to 
which Rockwood, Vitamins or any other entity under common control with any 
such entity pays Ritter or any entity owned or controlled by Ritter 
compensation based upon or arising out of the business activities of Rockwood 
or Vitamins.

     F.     Biomune intends to purchase 52% of the membership interests of 
Rockwood from Cypress for  $3,360,000 as follows:

          (1)  $250,000 cash upon execution of this Agreement;

          (2)  Execution and delivery of a promissory note payable to Cypress 
("Note") for $1,750,000, as provided in Paragraph 2, below.

          (3)  1,000,000 shares of Series G Preferred Stock of Biomune having 
the rights and preferences described in Paragraph 3, below.

          (4)  $360,000 as an offset against amounts paid to Ritter and/or 
Rockwood under previous agreements for the purchase of Rockwood.

                                AGREEMENT

     In consideration for the promises, conditions and warranties contained 
herein and in order to consummate such plan of reorganization, the parties 
hereto represent, warrant, covenant and agree as follows:

     1.     Condition Precedent.  Prior to the execution of this Agreement, 
Ritter and Cypress shall have caused Rockwood to succeed to all of the 
business and ownership of all of the assets of Cosmetics and Vitamins.
     
     2.     Cash Payment and the Biomune Note.  Upon execution and delivery of 
this Agreement (the "Closing"), in consideration for the sale and transfer of 
52 percent of the membership interest of Rockwood, Biomune pays to Cypress the 
sum of $250,000 by check and hereby delivers its Note payable to Cypress, 
together with the other consideration required by this Agreement.  Cypress 
hereby transfers, sells, assigns, and conveys to Biomune, 52 percent of the 
membership interest in Rockwood.  The principal amount of the Note is 
$1,750,000.  The form of the Note is attached hereto as Exhibit "A," by 
reference made a part hereof.  The Note is payable under the following terms:

          a.  Term of the Note:    15 months;
          
          b.  Payments:
          
                         -- $250,000 on June 15, 1998.

                         -- $750,000 on November 30, 1998; and
     
                         --  $250,000 each on March 31, 1999 and June 30, 1999

                         --  the balance of unpaid principal and interest on 
                             August 31, 1999.
     
          c. Security:    The Note is secured by a perfected pledge of the 
                          interest in Rockwood acquired by Biomune under this
                          Agreement.

          d.  Guarantee:  The Note is personally guaranteed ("Guarantee") by 
                          David G. Derrick ("Guarantor"), President and Chief 
                          Executive Officer of Biomune.

          e.  Default:    If Biomune fails to make a payment when due, following
                          notice and an opportunity to cure such default within
                          60 days of receipt of such notice, then Cypress may
                          pursue  foreclosure of the security  interest 
                          described in c., above, and it may pursue its rights 
                          under the Guarantee, provided, however, that it may 
                          only realize one remedy and, if satisfaction of the 
                          default is achieved through the Guarantee, then 
                          Cypress' rights under any foreclosure action will be 
                          assigned to Guarantor. Notwithstanding the foregoing,
                          if by December 15, 1998, Cypress has not received at 
                          least $900,000 of the principal amount owing under 
                          the Note, then Cypress may rescind this Agreement by 
                          giving written notice thereof to Biomune, and
                          retain all amounts paid to such date as liquidated 
                          damages and cancel all other agreements which 
                          are ancillary to this Agreement as null and void.  
                          The parties acknowledge and agree that the amount
                          of the liquidated damages stated herein is reasonable
                          under the circumstances.

          f. Adjustments: The principal amount of the Note will be reduced by 
                          the following (as disclosed in the Audit). Any 
                          reduction resulting from the following adjustments
                          will be applied to the final payment(s) under the 
                          Note.  

                          A reduction will be required:

                          -- if Rockwood has a negative net worth as of March 
                             31, 1998, then the Note (and the purchase price) 
                             will be reduced by the amount of such negative
                             net worth;

                          -- if average revenues are less than $3,700,000 for
                             Rockwood over the last three years then the Note 
                             and purchase price will be reduced by the amount
                             of such shortfall. 

          g.  Interest:  The note will bear interest at the rate of one percent
                         per annum over the "reference rate" of Bank of America
                         National Trust and Savings Association, as designated 
                         in the Note.  If there is an adjustment in the 
                         purchase price, there will be a corresponding 
                         adjustment to the amount of interest payable under 
                         the Note in proportion to the amount of such reduction.

          h.  Offsets:   Rockwood has disclosed certain litigation and other
                         contingent liabilities that may adversely affect its
                         profitability and the value of its business.  The 
                         parties will cooperate with the auditors to 
                         establish appropriate reserves for such liabilities 
                         and the purchase price and Note will be adjusted to
                         reflect the reduction in the value of Rockwood, if 
                         any, that results from such contingencies.
               
     3.     The Series G Preferred Stock.  As part of the purchase price paid 
by Biomune, Biomune will issue to Cypress 1,000,000 shares of Series G 
Preferred Stock (the "Series G Preferred").  The Series G Preferred will have 
the rights and preferences set forth in the "Designation of Rights and 
Preferences of Series G Preferred Stock" attached to this Agreement as Exhibit 
"B" ("Designation") and by this reference made a part hereof.  The rights and 
preferences include, but are not limited to, the following (all of which are 
qualified in their entirety by the provisions of the Designation attached as 
Exhibit "B"):

     a. Dividends: 8% dividend per year, payable in either cash or stock, at 
the sole discretion of Biomune.
     
     b. Seniority: the Series G Preferred will rank senior to the Common Stock
of Biomune, but junior in preference to the previously issued and outstanding 
Preferred Stock of Biomune.
     
     c. Conversion: the Series G Preferred will be convertible to Common Stock
of Biomune at the rate of one share of Common Stock for one share of Series G 
Preferred, subject to the limitations stated elsewhere in the Designation.
     
     d. Conversion Limitation: the conversion of the Series G Preferred will be
limited.  No conversion may be made if, immediately following the conversion, 
the holder of the converted shares of Series G Preferred will then own, as a 
result of such conversion or otherwise, more than 4.9% of the total issued and 
outstanding Common Stock of Biomune.  In addition, the conversion of all 
shares of Series G Preferred (as a class) may not result in issuance of more 
than 19% of the issued and outstanding shares of Biomune Common Stock 
immediately prior to such conversion.
     
     e. Liquidation: upon liquidation, the Series G Preferred will be entitled
to a liquidation preference of $1.00 per share.
     
     f. Voting Rights: the Series G Preferred will be non-voting stock and 
holders will not be entitled to any right to vote any of the underlying Common 
Stock until such time as the Series G Preferred has been converted to Common 
Stock; except for those instances under Nevada law in which the shares may 
vote as a class on certain matters.
     
     g. Redemption Rights: Biomune may redeem the Series G Preferred, at its 
sole election and subject to a prior right of conversion, under certain 
circumstances and in connection with certain transactions following notice to 
the holder(s) of the Series G Preferred.  The redemption price will be as set 
forth in the notice of redemption, but will not be less than $1.00 per share.
     
     h. Adjustments: the Series G Preferred will be subject to certain 
adjustments in the event of corporate reorganizations and similar transactions 
as set forth in the Designation.
     
     i. Release of Shares.  The shares of Series G Preferred will be released 
and delivered to Cypress in blocks of 250,000 shares.  Each block will be 
released on the fifteenth business day following any calendar quarter in which 
Rockwood realizes profits in excess of $250,000.  No shares will be issued 
after March 31, 2000 and any shares remaining undelivered at such date will be 
canceled and will not be deemed to have been issued.          

     4.     Line of Credit.  Following the closing, Biomune will make 
available or will cause to be made available to Rockwood, an operating line of 
credit of up to $1,000,000 (the "Line of Credit").  Amounts outstanding under 
the Line of Credit will bear interest at the prime rate plus one percent (the 
prime rate being the prime rate established by the principal bank used by 
Biomune in its business transactions or another national financial institution 
selected by Biomune).  Interest on outstanding amounts will be payable 
monthly.  The Line of Credit will be secured by a perfected security interest 
in all of the assets, accounts receivable, inventory and other property of 
Rockwood and Rockwood will sign and agree to filing of all forms and 
agreements reasonably requested by Biomune for the purpose of perfecting such 
security interest.  The term of the Line of Credit will be for one year; 
provided, however, that if there is no default under the Line of Credit at the 
end of such term (and any renewal thereof), the Line of Credit may be renewed 
on substantially the same terms and conditions for up to two (2) consecutive 
one-year renewal terms.   No equity distributions will be made by Rockwood 
(except as necessary for the payment of taxes) in any year in which the Line 
of Credit has not been paid in full, without the prior written consent of 
Biomune.  Amounts loaned to Rockwood prior to the closing will be deemed to 
have been loaned pursuant to and will be rolled into the Line of Credit.  In 
the event of a default under the Note which is not cured and following which 
Cypress shall exercise its right to rescind this transaction or to foreclose 
on the collateral for such Note, all amounts outstanding on the Line of Credit 
will be converted to a promissory note, with interest continuing at the rate 
then applicable (the "Rockwood Note").  The principal and unpaid interest 
under the Rockwood Note will be amortized and payable over 18 months from the 
original maturity date, with monthly payments of principal and interest.  The 
security interest will not be released until the Rockwood Note is paid in full 
together with all interest thereon.
     
     5.     Rockwood Operating Agreement.  The operations of Rockwood 
following closing will be conducted pursuant to and under the terms of an 
Operating Agreement in form and content substantially as the Operating 
Agreement attached to this Agreement as Exhibit "C" and by this reference 
incorporated herein.  Andela Group, Inc. ("Andela"), a California corporation 
owned and controlled by Ritter will be the manager of Rockwood, and will 
provide the personal services of Ritter on behalf of Rockwood with the title 
of "President." A "Board of Directors" will direct the activities of the 
manager and other executives of Rockwood.  One member of the board will be 
appointed by Cypress and two will be appointed by Biomune.  Voting on matters 
properly before the members of Rockwood will be according to their respective 
equity (member) interest.  Andela's engagement as manager and compensation 
(including Ritter's employment as President) will be governed by a five-year 
agreement in form and content substantially as that "Management Agreement" 
attached hereto as Exhibit "D" and by this reference incorporated in and made 
a part of this Agreement. 

     6.     Closing.  The Closing will occur on the date this Agreement is 
executed, however, subject to the terms and conditions contained in this 
Agreement, the Closing shall be effective as of April 1, 1998.

     7.     Representations and Warranties of the Parties.  The parties to 
this Agreement and Rockwood represent and warrant to each and every other 
party to this Agreement as of the date of this Agreement and as of the date of 
Closing as follows:

          a. Litigation.  Except for disclosure, if any, to the other parties 
in writing prior to the execution of this Agreement and as listed on Exhibit 
"E" attached hereto and by this reference incorporated herein, there are no 
actions, suits or proceedings pending or to each party's respective knowledge 
threatened against or affecting the properties or business of any party before 
any court or before or by any federal, state, municipal or other governmental 
department, commission, board, bureau, agency or instrumentality which, if 
adversely determined, would materially and adversely affect such business or 
properties, considered as a whole.  Each party to its knowledge is not in 
default with respect to any order, writ, injunction or decree of any court or 
any such governmental department, commission, board, bureau, agency or 
instrumentality which would materially and adversely affect its business or 
properties, considered as a whole.
          
          b. Absence of Changes or Events.  Unless disclosed in writing to and
acknowledged by the other parties prior to the execution of this Agreement 
(or, in the case of Biomune, to the extent not disclosed in its annual report 
on Form 10-K for the year ended September 30, 1997 or any intervening 
quarterly or current report filed with the Securities and Exchange 
Commission), or unless done with the other parties' written consent or as 
contemplated by this Agreement, no party hereto has since December 31, 1998:
          
     (i) Incurred any material amount of obligations or liabilities (absolute, 
accrued, contingent or otherwise) except in the ordinary course of business;

     (ii) Discharged or satisfied any material amount of liens or encumbrances, 
or paid or satisfied any material amount of obligations or liabilities 
(absolute, accrued, contingent or otherwise) other than (a) those shown or 
reflected in the party's most recent financial statements or existing at the 
time thereof but which under generally accepted accounting principles were not 
required to be reflected thereon and (b) those incurred since the date of the 
most recent financial statements of the parties in the ordinary course of 
business;

     (iii) Mortgaged, pledged or subjected to any material lien, charge or 
other encumbrance any of its assets, tangible or intangible;

     (iv) Except in the ordinary course of business, written up or down 
the value of any inventory or written off as uncollectible any notes or 
accounts receivable or any portion thereof;

     (v) Sold or transferred any material amount of its assets or canceled any
debts or claims, or waived any rights of substantial value except in the 
ordinary course of business;

     (vi) Except for the repair or replacement of damaged or destroyed property
out of the proceeds of insurance, made, or made any commitment for, any one 
capital expenditure in excess of $5,000;

     (vii) In the case of Rockwood, made any declaration, setting aside or 
payment to its members of any distribution in respect of its Capital Account 
or redeemed or purchased or otherwise acquired any of its Capital Account 
interests or agreed to take any such action;

     (viii) Experienced any material adverse change in its financial position,
assets or liabilities;

     (ix) Made any material change in its credit or collection policies or 
sales policies;

     (x) Entered into any material transaction other than in the ordinary 
course of business;

     (xi) Issued any membership interests, partnership interests, stocks, 
bonds, convertible debentures, or other equity securities, or become obligated 
on or in respect of any such securities or granted any stock options; or

     (xii) In the case of Rockwood, borrowed any funds.

          c. Disclosure.  No representation or warranty by any party contained
in this Agreement and no statement contained in any exhibit or other 
instrument specified in this Agreement contains or was prepared in reliance or 
based upon any untrue statement of a material fact, or omits to state a 
material fact necessary to make the statements contained therein not 
misleading.

     8.     Representations and Warranties of Ritter and Rockwood.  In 
addition to the representations and warranties made in Section 7 of this 
Agreement, Cypress, Ritter and Rockwood, and each of them, additionally 
represent and warrant to Biomune as follows:

          a. Cypress owns all the rights, title and interests in Rockwood as 
outlined in the Recitals hereto.  There are no liens, pledges or encumbrances 
affecting any of the right, title or interest in Rockwood nor will this 
Agreement violate or breach any other agreements to which Cypress, Ritter or 
Rockwood, or any of them, is a party.
          
          b. Rockwood owns all the rights, title and interests as outlined in 
the Recitals hereto and conducts the business indicated therein.    There are 
no liens, pledges or encumbrances affecting any of the right, title or 
interest in Rockwood or its business and this Agreement will not violate or 
breach any other agreements to which Rockwood is a party.
          
          c. The March 31, 1998 Audit of Rockwood and all disclosures of any 
relevant information related thereto which have been made to the accountants 
in the preparation of these financial statements, are true, complete and 
accurate in every respect and shall disclose a positive net worth as of such 
date (or the Note will be reduced as provided in Section 2, above).  Rockwood 
and its affiliates, including Ritter, will cooperate fully with Biomune and 
the auditor selected by Biomune to prepare the Audit.
          
          d. Attached hereto as Exhibit "F" is a copy of the most recent 
financial statements of Rockwood and its predecessors.  Except for those 
liabilities shown on the financial statements attached hereto as Exhibit "F," 
there are no outstanding claims, liabilities or causes of action against 
Rockwood or any subsidiary, principal or affiliate of Rockwood.
          
          e. No representation or warranty by Cypress, Ritter or Rockwood 
contained in this Agreement and no statement contained in any exhibit or other 
instrument specified in this Agreement contains or was prepared in reliance or 
based upon any untrue statement of a material fact, or omits to state a 
material fact necessary to make the statements contained therein not 
misleading.

     9.     Conditions Precedent for Obligations of Biomune.  All obligations 
of Biomune under this Agreement are subject to the fulfillment of each of the 
following conditions prior to or at the Closing:

          a. All proceedings taken in connection with the transactions 
contemplated herein and all instruments and documents required in connection 
therewith or incident thereto shall be satisfactory in form to Biomune and its 
counsel.
          
          b. Except for changes in the ordinary course of business, the 
representations and warranties of the other parties contained in this 
Agreement or in any certificate or document delivered to Biomune pursuant 
hereto shall be true and correct in all material respects as of the Closing, 
subject to any changes and exceptions thereto which are consented to by 
Biomune or are contemplated by this Agreement.
          
          c. The transfers of interest, agreements and undertakings 
contemplated by Sections 1 through 7 above have been completed in full.
          
          d. Andela shall execute and deliver the Management Agreement.

     10.     Survival of Representations and Warranties and Indemnification 
for their Breach. All representations, warranties and covenants of the parties 
or some of the parties hereto as set forth in this Agreement shall be true as 
of the time of and, together with the agreements set forth herein, shall 
survive the Closing date hereunder. The parties, jointly and severally, agree 
that any party who has breached or breaches any representation warranty or 
covenant, shall protect, indemnify and save harmless any other non-breaching 
party or parties from and against any and all claims, demands, liabilities, 
demands, damages, or causes of action of every kind and character resulting 
from any breach thereof by the breaching party.

     11.     Commissions and Finder's Fees.  Each of the parties represents 
and warrants that the negotiations relating to this Agreement and the 
transactions contemplated hereby will not give rise to any valid claims 
against any other party for a brokerage commission, finder's fee, or other 
like payment.

     12.     Tax Matters.   Each party or the pass-through entities or 
individuals shall be responsible for income and/or franchise taxes and product 
liability claims for occurrences prior to and up to the date of this 
Agreement.  The tax returns of Rockwood shall be prepared and filed and 
elections and allocations made so as to give Ritter the best possible 
advantage under the tax laws.  Similarly, it is anticipated that the terms of 
the purchase of the Rockwood interest by Biomune hereunder will be treated by 
the parties in such a way as to provide the best possible advantage under tax 
laws for the parties.

     13.     Notices.  All notices, requests, and other communications 
hereunder shall be in writing and shall be deemed to have been duly given if 
delivered, or mailed first class postage prepaid:

          If to Cypress: Cypress Springs LLC
                         Ira E. Ritter, Manager
                         11845 West Olympic Boulevard, Suite 710
                         Los Angeles, California 90064
                         Facsimile No.:  (310) 479-5902

          with a copy to:  Riordan & McKinzie
                           300 South Grand Avenue, 29th Floor
                           Los Angeles, California 90071
                           Attention:  Thomas L. Harnsberger, Esq.
                           Facsimile No.:  (213) 229-8550

          If to Biomune: Biomune Systems, Inc.
                         2401 South Foothill Drive
                         Salt Lake City, Utah 84109
                         Attention:  David G. Derrick, CEO
                         Facsimile No.:  (801) 466-3741

          with a copy to: Durham, Evans, Jones & Pinegar
                          50 South Main Street, Suite 850
                          Salt Lake City, Utah 84144
                          Attention:  Kevin R. Pinegar, Esq.
                          Facsimile No.:  (801) 538-2425

Such names and addresses may be changed by written notice thereof to all of 
the parties hereto.

     14.     Entire Agreement and Amendments.  This Agreement, including the 
exhibits referred to herein which are a part hereof, contains the entire 
understanding of the parties hereto with respect to the subject matter 
contained herein and may be amended only by a written instrument executed by 
all affected parties.  There are no restrictions, promises, warranties, 
covenants or undertakings other than those expressly set forth herein.  The 
section and paragraph headings contained in this Agreement are for reference 
purposes only and shall not affect in any way the meaning or interpretation of 
this Agreement.

     15.     Counterparts.  This Agreement may be executed simultaneously in 
two or more counterparts, each of which shall be deemed an original but all of 
which together shall constitute one and the same instrument.

     16.     Parties in Interest.  This Agreement shall not be assignable by 
any party, shall be binding upon each party and their respective successors 
and, except as otherwise expressly provided, shall inure only to the benefit 
of the parties signatory to this Agreement and any persons receiving any 
consideration in this reorganization.

     17.     Costs.  Except as otherwise provided herein or by separate 
agreement, the parties shall each pay their own expenses and costs incurred in 
connection with negotiating, preparing and consummating the transactions 
contemplated by this Agreement, including but not limited to fees and expenses 
of their attorneys and accountants.

     18.     Governing Law.  This Agreement shall be construed, interpreted, 
governed by and enforced in accordance with the laws of the state of 
California and the parties hereto submit to personal jurisdiction of such 
courts and waive any objections based on lack of personal jurisdiction, 
improper venue or forum non conveniens to the conduct of any proceeding in any 
such court

     19.     Savings Clause.  In the event that any term of this Agreement is 
deemed by any court of competent jurisdiction to be overly broad in scope, 
duration or area of applicability, the court considering the same shall have 
the power and is hereby authorized and directed to limit such scope, duration 
or area of applicability, or all of them, so that such term or provision is no 
longer overly broad and to enforce the same as so limited.  Subject to the 
foregoing sentence, in the event any provision of this Agreement will be held 
to be invalid or unenforceable for any reason, such invalidity or 
unenforceability will attach only to such provision and will not affect or 
render invalid or unenforceable any other provision of this Agreement.

<PAGE>
     IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement 
on the date first above written.


                              BIOMUNE SYSTEMS, INC., 
                              a Nevada corporation 

                                   /s/ David G. Derrick
                              By:_______________________________ 
                                   President and CEO
                              Its:_______________________________

                              CYPRESS SPRINGS LLC

                                   /s/ Ira E. Ritter
                              By:_______________________________
                                   Manager
                              Its:_______________________________    

                              IRA E. RITTER

                              /s/ Ira E. Ritter
                              _______________________________


ACKNOWLEDGED AND AGREED:                              

                              ROCKWOOD COMPANIES LLC    
                              a California limited liability company 

                                   Ira E. Ritter
                              By:_______________________________ 
                                   Manager
                              Its:_______________________________ 







                          ROCKWOOD COMPANIES LLC 
                          MANAGEMENT AGREEMENT

     THIS MANAGEMENT AGREEMENT is entered into as of the 27th day of May 1998, 
by and among ANDELA GROUP, INC., a California corporation ("Andela"); IRA E. 
RITTER, an individual residing in California and the principal stockholder of 
Andela ("Ritter") and ROCKWOOD COMPANIES, LLC, a California Limited Liability 
Company ("Company"). 

     Cypress Springs, LLC ("Cypress") and Biomune Systems, Inc. ("Biomune") 
are the members of Company and own all of the outstanding interests, 48 
percent by Cypress and 52 percent by Biomune.

     Ritter has agreed to act as the President of the Company on the terms and 
conditions set forth in this Agreement for the management of the Company.  The 
services of Ritter will be provided through Andela.  The services of Ritter 
are personal, notwithstanding the fact that compensation for such services 
will be paid consistent with the terms of this Agreement to Andela.  As used 
in this Agreement, the term "Manager" will refer to Ritter and Andela 
collectively, unless the context clearly provides to the contrary.

     NOW, THEREFORE, in consideration of the foregoing recitals and the mutual 
agreement hereinafter set forth, the parties hereto agree as follows:

     1.     Engagement of Manager.  The Company hereby engages Manager, and 
Manager accepts such engagement to manage and operate the business and 
administrative operations of the Company upon the terms and conditions 
hereinafter set forth.

     2.     Effective Date & Terms.  This Agreement shall become effective as 
of the date it is executed by all of the parties hereto (the "Effective 
Date"), and shall continue in full force and effect commencing with the 
Effective Date and shall thereafter continue for a period of 60 months (the 
"Initial Term").  Either party may terminate this Agreement at any time by 
giving to the other a sixty (60) day prior written notice of such 
termination.  In the event that no such termination notice is given by either 
party prior to the end of the Initial Term, this Agreement shall continue in 
full force and effect for an additional twelve (12) month renewals (the 
'Renewal Term") with the same sixty (60) day termination privileges prior to 
each anniversary date (subject, as provided above, to the right of any party 
to terminate the Agreement at any time).

     3.     Duties and Authority of Manager.  Manager's duty and authority 
shall consist of the following:

          (a)     Books and Records.  Maintain full and accurate books and 
records of the accounts of the Company, which shall be open to the inspection 
of the members of Company at the office of Manager upon reasonable notice, but 
in no event less than three (3) working days.

          (b)     Monthly Statements.  Render a monthly statement of receipts, 
disbursements, and charges to the Members.  Manager shall prepare and mail 
said monthly reports on or before the tenth (10th) day of each calendar month 
for the immediate preceding month.

          (c)     Deposit Collections.  Deposit all receipts collected for the 
Company in Company's account, with the bank or savings institution chosen by 
Biomune.  Manager will not be held liable in event of bankruptcy or failure of 
any depository chosen, so long as such depository is insured by any branch of 
the United States Government.

          (d)     Grant of Authority to Manage.  The Company hereby gives 
Manager the following authority and powers (all or any of which may be 
exercised in the name of the Company) and the Company agrees to assume all 
expenses in connection therewith:

               (1)     To advertise the availability of the Company's products 
and services; to sign, renew, or cancel leases and other agreements for the 
Company; to collect royalties, payments or other charges and expenses due, and 
give receipts therefore, to terminate agreements and to sign and serve in the 
name of the Company such notices as are appropriate thereto; to institute and 
prosecute actions and to recover possession of business property or assets in 
the name of the Company and recover rents and other sums due; and when 
expedient, to settle, compromise, and release such actions or suits or 
reinstate such tenancies.  Company shall reimburse Manager for all actual 
expenses of such actions including, but not limited to, attorneys' fees, 
filing fees (before, during and after litigation) and court costs, which 
Manager does not recover in such actions.

               (2)     To oversee the management of the Company, using his 
best skill and efforts to serve the Company and its customers, as from time to 
time directed by the Board of Directors of the Company;

               (3)     Make or cause to be made and supervise all ordinary 
repairs and replacements necessary to preserve the premises and property of 
the Company in good and serviceable condition and for the operating efficiency 
thereof; to enter into agreements for all necessary repairs, maintenance, 
minor alteration and utility services; and to purchase supplies and pay all 
bills.   Manager shall secure the approval of the Board for any expenditures 
in excess of Twenty-Five Thousand Dollars ($25,000.00) for any one (1) item, 
except monthly or recurring operating charges, debt servicing, or taxes;

               (4)     To employ, supervise, discharge and pay on behalf of 
the Company all employees, contractors and agents necessary for the efficient 
operation and maintenance of Company.  Manager shall not be liable to the 
Company for any act or omission on the part of any such employee, contractor 
or agent if Manager has taken reasonable care in his employment;

               (5)     To pay loan indebtedness, property and employee's taxes 
and special assessments, if any;

               (6)     To place with responsible insurance companies, fire, 
liability, workman's compensation, or any other insurance necessary for the 
Company's protection.  Company shall hold Manager harmless from any and all 
liability arising from any other cause relating to the procuring and 
maintaining of insurance in connection with the Company.  The Company hereby 
waives all of its rights and those of its insurers with respect to recovery 
against Manager and the officers, employees, and representatives of the 
Company on account of loss or damage to property where such loss arising out 
of or in connection with the business of the Company is caused by an insurable 
peril, including but not limited to, fire or any of the extended coverage 
hazards.  Company shall give notice to the insurance carrier(s) that the 
foregoing waiver subrogation is contained in this Agreement;

               (7)     To pay on behalf of the Company all charges and 
operating expenses of the Company with checks issued on behalf of the Company 
and reviewed by Michael G. Acton and bearing two (2) signatures of authorized 
officers of the Company one of whom may be the President, for all payments in 
excess of $2,500;

               (8)     In addition to the foregoing, Manager shall perform all 
services which are necessary for, and shall use due diligence in the operation 
and management of the Company, and shall report to the Members promptly any 
conditions at, on or about the business of the Company which, in the opinion 
of Manager, require the attention of the Members.

     4.     Compensation.  As compensation for the services to be rendered by 
Manager pursuant to this Agreement, the Company shall pay to Manager:

          (a)     Annual Fee.  An annual management fee of $200,000 payable in 
equal installments monthly. 

          (b)     Cash Bonus.     An annual cash bonus equal to 20 percent of 
the annual net pre-tax income of the Company in excess of $1,000,000.  Said 
bonus will be payable within sixty (60) days of the end of each fiscal year of 
the Company.

     5.     Expense Reimbursement.  The Company shall reimburse Manager for 
ordinary and reasonable expenses incurred in connection with the fulfillment 
of Manager's duties under this Agreement, including, but not limited to 
authorized automobile (with an allowance not to exceed $1,600 per month), 
telephone, telefax, travel expenses (including meals and lodging), and mail 
expenses.

     6.     Use of the Manager's Own Funds.  Notwithstanding any contrary 
provision herein, Manager shall not be obligated to use or advance any of its 
own funds or to incur any obligations on its own behalf with respect to any of 
the expenses or obligations in connection with the Company.  If however, any 
such expenses are paid out of Manager's own funds, it shall be entitled to 
reimbursement from the Company therefore.

     7.     Exclusivity of Agency.  During the term of this Agreement, the 
Company shall not authorize any other person, firm, or corporation to act as 
Manager with respect to the Company or to perform any of the duties of Manager 
hereunder.

     8.     Principal and Agent.  With respect to all acts, obligations, 
rights, liabilities, and duties arising by reason of this Agreement, 
Management will at all times act as the agent of the Company who is the 
principal. 

     9.     Indemnifications.  The Company shall indemnify Manager and hold it 
harmless from and against any and/or all losses, damages, liabilities, and 
expenses, including costs and reasonable attorney's fees which Manager may 
incur by reason of or in connection with any injury or damage or claim of 
injury or damage of any kind including, but not limited to, those arising out 
any kind whatsoever and to whomever belonging, including the Company, in any 
way relating to the  performance or exercise of any of the duties, 
obligations, powers or authorities herein or hereafter granted to Manager.

     10.     Covenant Not to Compete.     Manager agrees that during the Term 
of this Agreement, the Manager shall not, directly or indirectly, in any 
capacity, engage or participate in, or become employed by or render advisory 
or consulting or other services in connection with any Prohibited Business as 
defined in below.  During the Term, the Manager shall not make any financial 
investment, whether in the form of equity or debt, or own any interest, 
directly or indirectly, in any Prohibited Business.  Nothing in this Section 
shall, however, restrict the Manager from making any passive investment in any 
private company or entity or in any company whose stock is listed on a 
national securities exchange or actively traded in the over-the-counter 
market; provided that (i) such investment does not give the Manager the right 
or ability to control or influence the policy decisions of any Prohibited 
Business, and (ii) such investment does not create a conflict of interest 
between the Manager's duties hereunder and the Manager's interest in such 
investment.  For purposes of this Section, "Prohibited Business" shall be 
defined as any business and any branch, office or operation thereof, which is 
a competitor of the Company in providing similar goods and services to the 
biopharmaceutical, nutraceutical, vitamin, health and beauty aids businesses 
and which has established or seeks to establish contact, in whatever form 
(including but not limited to solicitation of sales, or the receipt or 
submission of bids), with any entity that is at any time a client, customer or 
supplier of the Company (including but not limited to all subdivisions of the 
federal government).  During the Term, the Manager of the Company or its 
successors in interest to leave his or her employment with the Company or its 
successors in interest; (b) employ, hire, solicit or cause to be employed, 
hired or solicited (other than by the Company or its successors in interest), 
or encourage others to employ or hire any person who within two (2) years 
prior thereto was employed by the Company or its successors in interest; or 
(c) establish a business with, or encourage others to establish a business 
with, any person who within two (2) years prior thereto was an employee or 
supplier of the Company or its successors in interest.  The provisions of this 
Section shall survive the termination of this Agreement for a period of two 
years, irrespective of the reasons therefor if termination occurs prior to the 
end of the Term stated in Paragraph 2 hereof, provided, in any such event, 
that the payments to Manager provided for under Paragraph 4 continue to be 
made.  The Manager acknowledges and agrees that the restrictions imposed upon 
it by this Section and the purpose of such restrictions are reasonable and are 
designed to protect the continued success of the Company without unduly 
restricting the Manager's future employment by others.  Furthermore, the 
Manager acknowledges that, in view of the Information which the Manager has or 
will acquire or has or will have access to and in view of the necessity of the 
restrictions contained in this Section,  any violation hereof would cause 
irreparable injury to the Company and its successors in interest with respect 
to the resulting disruption in their operations.  By reason of the foregoing, 
the Manager consents and agrees that if Manager violates any of the provisions 
of  this Section and the Company and its successors in interest as the case 
may be, shall be entitled, in addition to any other remedies that they may 
have, including money damages, to an injunction to be issued by a court of 
competent jurisdiction, restraining the Manager from committing or continuing 
any violation of such Section of this Agreement.  In the event of any 
violation of this Section, the Manager further agrees that the time periods 
set forth in such Section shall be extended by the period of such violation.

     11.     Default.  If either party hereto defaults in the performance of 
any of its obligations hereunder at any time during the term of this 
Agreement, the other party, in addition to any other rights or remedies it may 
have, shall have the right to terminate this Agreement by serving notice on 
the defaulting party describing the default and setting forth a date for such 
termination which shall not be less than ten (10) days after such service.  If 
the default so specified is not cured by the defaulting party prior to the 
date so set for termination, this Agreement shall terminate on such date; 
provided, however, that is such default is incapable of being cured within 
such period, the same shall not be the basis for termination hereunder if the 
defaulting party commences to cure the same during such period and thereafter 
diligently prosecutes the cure to completion.  Upon any such termination, 
Manager shall deliver possession of the business of the Company to Biomune or 
its nominee.

     12.     Attorneys' Fees.  If any action at law or in equity, including an 
action for declaratory relief, is brought to enforce or interpret the 
provisions of this Agreement, the prevailing party shall be entitled to a 
reasonable attorneys' fees which may be set by the court tin the same action 
or in a separate action brought for that purpose in addition to any other 
relief to which he or it may be entitled. 

     13.     Notices.  All notices and demands of any kind which either party 
hereto may be required or desires to served upon the other party under the 
terms of this Agreement shall be in writing and shall be served upon such 
other party by personal service upon such other party, or by mailing a copy 
thereof by certified or registered mail, postage prepaid, with return receipt 
requested, addressed as follows:

          If to "Company":    ROCKWOOD COMPANIES, LLC
                              11845 West Olympic Boulevard
                              Suite 710
                              Los Angeles, California 90064

          With a copy to:     Biomune Systems, Inc.
                              2401 South Foothill Boulevard
                              Salt Lake City, Utah 84109
                              Attn: President

          If to "Manager"     Andela Group Inc.
          or "Ritter":        11845 West Olympic Blvd., Suite 710
                              Los Angeles, California 90064

     14.     Entire Agreement.  This agreement represents the entire Agreement 
and understanding between the Company and Manager.  There are no oral 
agreements or understandings outside this Agreement.  However, Company and 
Manager agree to execute such other instruments and agreements as are 
reasonably necessary to perform their obligations hereunder.

     15.     Agreement Severable.  If any clause of this Agreement is found to 
be unenforceable at law or in equity the remainder of this Agreement shall 
remain in full force and effect between the parties hereto.

     16.     Successors and Assigns.  Management may delegate any of its 
duties hereunder but no such delegation shall relieve Management of any of its 
obligations hereunder.  Except as provided in the proceeding sentence, neither 
party may assign this Agreement of any interest herein without the prior 
written consent of the other party.  Subject to the foregoing restrictions, 
this Agreement shall be binding upon and shall inure to the benefit of the 
heirs, executors, administrators, successors and assigns of the parties 
hereto.

     17.     Termination, Removal, Replacement of Manager.  Manager shall have 
no authority to admit a person or entity as a Manager or substitute manager of 
the Company without the written consent or ratification of the specific act by 
majority vote of the Members.  The death, retirement, disability, resignation 
or expulsion of Ritter as President or the legal incapacity, dissolution, 
bankruptcy, insolvency or expulsion of Manager shall not operate to terminate 
the Company and in any such event another Manager may be chosen by the Members 
to replace a Manager who has died, retired, become disabled, resigned, been 
expelled, or otherwise indicated its inability to continue as a Manager unless 
Members entitled to receive a majority of the profits of the Company agree 
that it is not necessary to replace said Manager.  A replacement Manager shall 
be chosen only from among the Members and persons, entities, or interests 
related to Members, by the vote of Members who are entitled to receive a 
majority of the capital of the Company in a vote in which all Members may 
participate.   This Agreement will terminate upon any of the above 
occurrences.

     18.     Paragraph Headings.  The headings of the several paragraphs and 
subparagraphs of this Agreement are inserted solely for convenience of 
reference, and are not a part of and are not intended to govern, limit or aid 
in the construction of any term or provision hereof.

     19.     Governing Law.  This Agreement shall be governed by and construed 
in accordance with the laws of the State of California.





[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK.]

<PAGE>

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement the 
day and year first hereinabove written.

                              ROCKWOOD COMPANIES, LLC
                              a California limited liability company
                              
                                   /s/ Ira E. Ritter
                              By:____________________________________
                                   Manager


                               ANDELA GROUP, INC.

                                   /s/ Ira E. Ritter
                              By:____________________________________
                                   President



                                   /s/ Ira E. Ritter
                                    _______________________________________
                                   Ira E. Ritter





<PAGE>
                            LINE OF CREDIT AGREEMENT

     This Line of Credit Agreement (the "Agreement") is made and entered into 
in Salt Lake City, Utah, this 27th day of May, 1998, by and between Biomune 
Systems, Inc., a Nevada corporation ("Lender"), and Rockwood Companies, LLC, a 
California limited liability company ("Borrower").

                              R E C I T A L S

     A.     Borrower is a California limited liability company engaged in the 
business of manufacturing, marketing and distributing vitamins, nutritional, 
personal, skin and beauty products (the "Business");

     B.     Borrower desires or may desire from time to time to obtain 
financing from Lender pursuant to this Agreement for the purpose of funding 
the operations of the Business.

     C.     Lender is willing to make a line of credit (the "Credit Line") 
available to Borrower to provide financing for the Business upon the terms and 
conditions contained in this Agreement.  The Credit Line is an "advised 
guidance line" and not a committed credit facility, meaning that Borrower may 
request one or more Loans, as hereinafter defined, from Lender pursuant to 
this Agreement in connection with the Business, but the approval of such 
requests shall be in Lender's sole discretion.

     NOW, THEREFORE, in consideration of the mutual covenants contained 
herein, the parties agree as follows:

     1.     Credit Limit; Purposes and Uses.  Subject to all of the terms, 
conditions, covenants, and limitations contained in this Agreement, Lender 
hereby establishes the Credit Line for the benefit of Borrower pursuant to 
which Lender may make loans (each a "Loan") to Borrower in the aggregate 
principal amount of ONE MILLION AND NO/100 DOLLARS ($1,000,000.00) (the 
"Credit Limit").  The purpose of each Loan will be to provide funding for 
working capital of the Business in accordance with the Budget, as hereinafter 
defined, applicable to the Business.  Without Lender's prior written consent, 
none of the Loan proceeds shall be used for any purpose other than to pay 
those costs and expenses shown in the applicable Budget;  provided, however, 
(a) Borrower may, with the consent of Lender, reallocate to any line item in 
the Budget any excess amount remaining from another line item in the Budget 
after the payment of all costs and expenses with respect to such other line 
item; (b) Lender may use any undisbursed Loan proceeds, without regard to line 
item allocations in the Budget, to pay accrued interest and other fees and 
charges owed to Lender with respect to a Loan; and (c) Lender may, in its sole 
discretion, agree to advance Loan proceeds for purposes other than those 
described in the Budget, in excess of the amounts shown in any line item, or 
in excess of the approved Loan amount.  If Lender makes advances in accordance 
with the foregoing clause (c), Borrower agrees to pay such amount immediately 
upon demand by Lender.  Any request to make a Loan must be submitted to Lender 
prior to May 1, 1999 (the "Expiration Date"); provided, however, if a Loan has 
been approved prior to the Expiration Date, any undisbursed proceeds of such 
Loan shall continue to be available for disbursement after the Expiration Date 
in accordance with this Agreement and the corresponding Closing Advice, as 
hereinafter defined.  Upon execution of this Agreement, Borrower shall execute 
and deliver to Lender a promissory note (the "Note") in amount of the Credit 
Limit.  All advances and disbursements made pursuant to this Agreement shall 
be deemed principal advances under the Note.

     2.     Loan Amount.  Prior to the Expiration Date, Borrower may request 
that Lender make a Loan in such amounts as requested by Borrower; provided, 
however, the amount of any new Loan request when added to the amount of all 
prior approved Loans, will not exceed the Credit Limit. 

     3.     Loan Approval Process.  In connection with each request for a 
Loan, Borrower shall provide to Lender with such information, schedules, 
documents, and other agreements as Lender may require in order to evaluate and 
underwrite the proposed Loan, including without limitation the following:

          a.     An itemized budget (the "Budget") of business expenses and 
uses of the proceeds of the Loans;

          b.     Borrower's audited financial statements for its most recent 
fiscal year and interim periods preceding the loan request.

     The foregoing are referred to, collectively, as the "Loan Package."  Upon 
receipt of the completed Loan Package, Lender shall notify Borrower in writing 
whether it approves the Loan by sending to Borrower a "Closing Advice" in the 
form attached hereto as Exhibit A, appropriately completed.  Lender shall use 
its best efforts to so notify Borrower within fifteen (15) calendar days after 
Lender has received the completed Loan Package; provided, however, failure by 
Lender to notify Borrower of its decision within such time period shall not 
obligate Lender to make the Loan or otherwise subject it to any claim by 
Borrower.  Lender may, in its sole discretion, decide to make or decline any 
requested Loan.  The making of a Loan by Lender on one or more occasions shall 
not establish a course of conduct, business practice, or other commitment of 
Lender to make similar Loans in the future.

     4.     Loan Terms.  The terms of each Loan shall be set forth in the 
applicable Closing Advice.  In general, however, a Loan shall have a term of 
not more than twelve (12) months and a loan fee of 1.5% of the Loan amount.   
Interest will be payable monthly with principal and any unpaid accrued 
interest due at the end of the Loan term.  Unless Borrower notifies Lender in 
writing of any error in the Closing Advice within five (5) days after the 
Closing Advice is sent, the terms contained in the Closing Statement shall be 
conclusive and binding on the parties.  Lender may establish an account for 
each Loan in its books and records which shows all disbursements and payments 
with respect to the Loan.  Absent manifest error, such accounts shall be 
conclusive of the status of each Loan.

     5.     Disbursement Procedures.  Requests for draws, and disbursements of 
Loan proceeds, shall be made in accordance with the standard terms, 
conditions, policies, and procedures established from time to time by Lender 
with respect to similar loans; provided, however, Lender may make such 
modifications and adjustments to its standard terms, conditions, policies, and 
procedures as it, in good faith, deems appropriate for a particular Loan.  
Without limiting the foregoing, such terms, conditions, policies, and 
procedures (and any modifications and adjustments thereto) may establish the 
form of the draw request, the amount of any notice required to be given before 
a disbursement is made, the frequency of disbursements, any supporting 
documentation which must accompany a draw request (including inspections, 
evidence of costs and expenses pertaining to any disbursement), the manner in 
which disbursements will be made, any restrictions or limitations on the 
amount that can be disbursed, to whom disbursements will be made (including 
without limitation whether disbursements will be made directly to Borrower, 
directly to any vendor or supplier, or jointly to Borrower and any vendor or 
supplier), and conditions to the final disbursement.  Lender need not make any 
disbursement on a Loan if an Event of Default has occurred and is continuing, 
or any event has occurred or condition exists which, with the giving of notice 
or the passing of time or both, would constitute an Event of Default.  
Borrower shall designate in writing one or more persons who are authorized to 
request Loans and approve and direct disbursements thereunder (each an 
"Authorized Person").  Each Authorized Person may execute Closing Advices and 
Loan Documents, direct the disposition of Loan proceeds, and direct all other 
matters pertaining to this Agreement, the Loans, the Collateral, as 
hereinafter defined, and all matters in any way pertaining thereto.  Until 
notified otherwise, Borrower designates those persons whose names are shown 
after Borrower's signature at the end of this Agreement as Authorized Persons.

     6.     Interest; Repayment.  Interest will accrue on the outstanding 
principal balance of each Loan at the prime rate plus one percent published by 
Key Bank NA and in the manner described in the corresponding Closing Advice.  
Principal and interest for each Loan will be payable on the dates, in the 
manner, and upon the terms described in the corresponding Closing Advice.  
Notwithstanding the foregoing, Lender may, in its discretion, automatically 
make disbursements from a Loan to pay accrued interest and other fees and 
charges owed to it with respect to such Loan, even if by so doing the 
aggregate of all disbursements exceeds the principal amount of such Loan or 
the amount allocated in the Budget for the payment of interest.  Lender shall 
not be required to disburse funds from any Loan to pay accrued interest if  
(i) an Event of Default has occurred and is continuing, (ii) the funds 
allocated in such Loan's Budget for the payment of interest have been fully 
disbursed.  Borrower shall at all times remain liable for the payment of 
principal and interest on the Loan strictly in accordance with the terms of 
the Closing Advice, this Agreement, and the Note.

     7.     Fees; Other Expenses.  Borrower agrees to pay to Lender a loan fee 
in the amount of 1.5% of the Loan amount at the time a Loan is closed and in 
the amount of 1.5% of the outstanding aggregate amount on the Line of Credit 
at the time of each renewal thereof.  Such fee will be deemed to be fully 
earned and non-refundable at the time it is due and payable.  In addition, 
Borrower agrees to pay or reimburse Lender for all out-of-pocket costs and 
expenses incurred by Lender in connection with document preparation, recording 
and filing fees and related expenses.  Such fees and expenses shall be due and 
payable upon execution of this Agreement or the closing of any Loan, as the 
case may be, or if incurred thereafter, upon demand by Lender.  Borrower 
hereby authorizes Lender to pay all such fees, costs, and expenses from the 
Loan proceeds, without regard to line items established in the Budget for such 
Loan.

     8.     Collateral.  As security for all of Borrower's obligations, 
liabilities, indebtedness, and undertakings under this Agreement, Borrower 
shall grant Lender a security interest in all furnishings, fixtures, and 
equipment now or hereafter located on or attached to the premises of Borrower; 
all contracts, contract rights, accounts, and agreements with respect to the 
Business, and all permits and licenses; all accounts receivable and inventory 
of Borrower and any and all other real and personal property rights of 
Borrower described in the attached Financing Statement (collectively, the 
"Collateral").  At the time of each closing of a Loan, Borrower shall execute, 
acknowledge, and deliver to Lender a Financing Statement, in form and 
substance satisfactory to Lender, encumbering and granting a security interest 
in and to the Collateral.  At the time of each Loan closing, the lien of 
Lender under the Financing Statement shall constitute "first lien" that is 
senior in priority, interest, and right to all other liens, claims and 
encumbrances except the lien granted to Lender hereunder to secure any prior 
Loan, property taxes and assessments that are not yet due and payable, and 
liens of Far East Bank relating to Borrower's existing bank line of credit, 
purchase money security interests of trade creditors or vendors in the 
ordinary course of Borrower's business and such other encumbrances as Lender 
may approve.  Borrower agrees to execute and deliver to Lender, or shall cause 
to be executed and delivered to Lender, such other documents, certificates, 
resolutions, instruments, and agreements as Lender may reasonably request to 
further effect and perfect its security interest in the Collateral (all such 
documents, certificates, resolutions, instruments, and agreements, including 
this Agreement, the Note, and the Financing Statement, are referred to, 
collectively, as the "Loan Documents").

     9.     Conditions Precedent.  As to each Loan, Lender shall not be 
required to make any disbursement unless and until:

          a.     All of the Loan Documents required by Lender have been duly 
authorized, executed, and delivered to Lender by all of the parties thereto; 
have not been rescinded and remain in full force and effect; constitute the 
legal and binding obligations of all parties thereto; and are enforceable in 
accordance with their terms, except as may be limited by rules of bankruptcy 
and general equitable principles.  If necessary, the Loan Documents have been 
recorded or filed in the proper governmental office in order to perfect 
Lender's security interest in the Collateral.

          b.     Borrower has provided evidence satisfactory to Lender of the 
authority of Borrower, and each other signer of the Loan Documents, to enter 
into the Loan Documents and undertake the transactions and commitments 
contemplated therein.

          c.     Borrower has provided evidence satisfactory to Lender that 
all insurance policies and coverage required under the terms of this Agreement 
have been obtained and are in full force and effect.

          d.     The representations and warranties contained in the Loan 
Documents are then true with the same effect as though the representations and 
warranties had been made at such time.  The request by Borrower for a 
disbursement of proceeds from each Loan shall constitute a reaffirmation by 
Borrower to Lender that all representations and warranties made herein are and 
remain true and correct in all material respects to the same extent as though 
given at the time such request is made, and that all conditions precedent 
listed in this Paragraph have been, and continue to be, satisfied in all 
respects as of the date such request is made.

          e.     No Event of Default hereunder has occurred and is continuing, 
and no condition exists or event has occurred which, with the passing of time 
or the giving of notice or both, would constitute an Event of Default 
hereunder.

          f.     No material adverse change has occurred in the financial 
condition of Borrower since the date of any financial statements concerning it 
was last furnished to Lender.

          g.     The Collateral at all times will have fair market value at 
least equal to the aggregate amounts outstanding under this Agreement.

     10.     Representations and Warranties.  In order to induce Lender to 
enter into this  Agreement and to make the Loans provided for herein, Borrower 
represents and warrants to Lender as follows:

          a.     Borrower is a limited liability company duly organized, 
validly existing,  and in good standing under the laws of the state of 
California with the power to own its assets and to transact business in 
California, and in such other states where its business is conducted.

          b.     Borrower has all requisite authority and power to execute and 
deliver all Loan Documents required to be signed by it and to perform all 
terms, conditions, obligations, and undertakings imposed on it under the terms 
thereof.

          c.     The execution, delivery and performance of the Loan Documents 
and each other document incident hereto will not violate any provision of any 
applicable law, regulation, order, judgment, decree, article of organization, 
operating agreement, by-law, indenture, contract, agreement, or other 
undertaking to which Borrower is a party, or which purports to be binding on 
Borrower or its assets and will not result in the creation or imposition of a 
lien on any of its assets, other than the security interest granted to Lender 
and the Permitted Encumbrances.

          d.     There is no action, suit, investigation, or proceeding 
pending or, to the knowledge of Borrower, threatened, against or affecting 
Borrower or any of its assets which, if adversely determined (in any single 
instance or in the aggregate), would have a material adverse affect on the 
financial condition of Borrower, the operation of its business, or its 
abilities to perform timely all of its obligations under the Loan Documents.

          e.     Any financial statements which have heretofore been provided 
to Lender by Borrower, are correct, complete, and truly, fairly, and 
accurately represent the financial position of Borrower as of the date of such 
financial statements.  Since the date of such statements there have been no 
material adverse changes.

          f.     No information or report furnished by Borrower to Lender in 
connection with the negotiation of this Agreement contained any material 
misstatement of fact or omitted to state a material fact or any fact necessary 
to make the statements contained therein not misleading.

          g.     Borrower has (1) filed all applicable federal, state, and 
local tax returns or other statements required to be filed in connection with 
its business, including those for income taxes, sales taxes, property taxes, 
payroll taxes, payroll withholding amounts, FICA contributions, and similar 
items;  (2) maintained appropriate reserves for the accrual of the same; and 
(3) paid when due all such taxes, or sums or assessments made in connection 
therewith.  Provided, however, that (until distraint, foreclosure, sale, or 
similar proceedings have been commenced) nothing herein will require Borrower 
to pay any sum or assessment, the validity or amount of which is being 
contested in good faith by proceedings diligently pursued and as to which 
adequate reserves have been made.

          h.     Except as otherwise provided herein, Lender's security 
interest in the Collateral is a first lien position senior in right and title 
to all other liens, claims, and encumbrances of any kind except the Permitted 
Encumbrances.

          i.     To the best of Borrower's knowledge, the Budget provided with 
respect to each Loan is an accurate statement of all costs and expenses 
reasonably expected to be incurred in connection with the Business, and the 
amount of the Loan, together with revenues from operations of Borrower, are 
sufficient to meet the capital needs of Borrower.

          j.     All of the representations and warranties made by Borrower in 
the Loan Documents are true and correct in all material respects.

          k.     To the best of Borrower's knowledge, no Event of Default has 
occurred and is continuing, and no condition exists or event has occurred 
which, with the giving of notice or the passing of time or both, would 
constitute an Event of Default.

          l.     To the best of Borrower's knowledge, Borrower has complied 
with all applicable laws, rules, regulations, ordinances, and other 
requirements with respect to the operation of the Business.

     11.     Covenants.  With respect to each Loan, and at all times during 
which any funds are owing to Lender thereunder, Borrower covenants and agrees 
with Lender as follows:

          a.     Borrower will continue to operate its Business in the 
ordinary course and shall diligently pursue the same at all times prior to the 
maturity date of the Loan.

          b.     Borrower shall comply in all material respects with all laws, 
rules, regulations, ordinances, and other requirements imposed by any 
governmental or quasi-governmental body with respect to the operation of the 
Business.

          d.     Borrower shall perform in all material respects all duties 
and obligations imposed on it under or with respect to any contract in 
connection with the Business; provided, however, prior to any action by a 
party to such contracts to terminate the same, Borrower may contest in good 
faith any provision in such contracts by appropriate proceedings promptly 
initiated and diligently pursued.  Borrower shall promptly notify Lender of 
any default or claimed default under such contracts.

          e.     Borrower shall furnish such financial and other information 
concerning itself or the Business as Lender may reasonably request.

          f.     Borrower shall promptly notify Lender of any Event of Default 
or of any litigation, proceeding, or development which may have a material 
adverse effect on Borrower's ability to perform under the terms of the Loan 
Documents.

          g.     Borrower shall duly observe and conform to all valid 
requirements of any governmental authority relative to the conduct of its 
business, its properties, or its assets and will maintain and keep in full 
force and effect its existence as limited liability company and all licenses 
and permits necessary to the proper conduct of its business.

          h.     Borrower shall (1) file all applicable federal, state, and 
local tax returns or other statements required to be filed in connection with 
its business, including those for income taxes, sales taxes, property taxes, 
payroll taxes, payroll withholding amounts, FICA contributions, and similar 
items; (2) maintain appropriate reserves for the accrual of the same; and (3) 
pay when due all such taxes, or sums or assessments made in connection 
therewith.  Provided, however, that (until distraint, foreclosure, sale, or 
similar proceedings have been commenced) nothing herein will require Borrower 
to pay any sum or assessment, the validity of which is being contested in good 
faith by proceedings diligently pursued and as to which adequate reserves have 
been made.

          i.     Borrower shall not create or permit to exist any lien, claim, 
or encumbrance on the Collateral or any part thereof, except as granted to 
Lender and the Permitted Encumbrances.  Borrower shall promptly remove any 
lien, claim, or encumbrance that may be filed with respect to the Collateral 
other than the Permitted Encumbrances; provided, however, until distraint, 
notice of sale, sale, or similar proceedings have been instituted, Borrower 
may in good faith contest any such claims through proceedings promptly 
commenced and diligently pursued and as to which Borrower has made adequate 
reserves or given other evidence satisfactory to Lender that it can discharge 
such claims if they are upheld.  Borrower shall not do or refrain from doing 
any act which may in any manner adversely affect Lender's interest in the 
Collateral or diminish the value thereof.

          j.     Borrower will not make any equity distributions to its 
members (except to the extent reasonably required to comply with the 
obligations set forth in 11.h, above) if there has been or is any Event of 
Default which has not been cured or if the Line has not been paid in full at 
maturity.

     12.     Events of Default.  The occurrence of any of the following 
events, or the existence of any of the following conditions, shall constitute 
an Event of Default:

          a.     Failure to pay any principal or interest on any Loan within 
fifteen (15) days after the same becomes due.

          b.     Any representation or warranty made by Borrower in this 
Agreement, any Loan Document, or in connection with any borrowing or request 
for an advance hereunder, or in any certificate, financial statement, or other 
statement furnished by Borrower to Lender is untrue in any material respect at 
the time when made.

          c.     Default by Borrower in the observance or performance of any 
other covenant or agreement contained in this Agreement, other than a default 
constituting a separate and distinct event of default under this Paragraph 12, 
and the continuance of the same uncured for a period of  fifteen (15) days 
after notice thereof is given to Borrower.

          d.     Default by Borrower in the observance or performance of any 
other covenant or agreement contained in any other Loan Document or other 
agreement made and given in connection with this Agreement, other than a 
default constituting a separate and distinct event of default under this 
Paragraph 12, and the continuance of the same uncured for a period of thirty 
(30) days after notice thereof is given to Borrower.

          e.     Any of the Loan Documents for any reason ceases to be valid 
or in full force and effect or the validity or enforceability of which is 
challenged or disputed by any signer thereof, other than Lender.

          f.     Borrower shall default in the payment of principal or 
interest on any other obligation for borrowed money other than hereunder, or 
defaults in the payment of the deferred purchase price of property beyond the 
period of grace, if any, provided with respect thereto, or defaults in the 
performance or observance of any obligation or in any agreement relating 
thereto, if the effect of such default is to cause or permit the holder or 
holders of such obligation (or trustee on behalf of such holder or holders) to 
cause such obligation to become due prior to the stated maturity.

          g.     Filing by Borrower of a voluntary petition in bankruptcy 
seeking reorganization, arrangement or readjustment of debts, or any other 
relief under the Bankruptcy Code as amended or under any other insolvency act 
or law, state or federal, now or hereafter existing.

          h.     Filing of an involuntary petition against Borrower in 
bankruptcy seeking reorganization, arrangement or readjustment of debts, or 
any other relief under the Bankruptcy Code as amended, or under any other 
insolvency act or law, state or federal, now or hereafter existing, and the 
continuance thereof for sixty (60) days undismissed, unbonded, or 
undischarged.

          i.     Any of the Collateral, or all or any substantial part of the 
property of Borrower shall be condemned, seized, or otherwise appropriated, or 
custody or control of such property is assumed by any governmental agency or 
any court of competent jurisdiction, and is retained for a period of thirty 
(30) days.

          j.     Lender otherwise in good faith deems itself to be insecure, 
or the value of the Collateral to have significantly declined from the date 
hereof, or the prospect of timely payment or performance to be impaired, 
provided, however, Lender shall have given Borrower written notice of the 
grounds thereof, and Borrower shall have failed to correct such matter or 
given Lender other assurance satisfactory to Lender within twenty (20) days 
thereof.

     13.     Remedies.  Upon the occurrence of an Event of Default, Lender may 
declare the entire unpaid principal balance of all Loans, together with 
accrued interest thereon, to be immediately due and payable without 
presentment, demand, protest, or other notice of any kind, except as otherwise 
expressly required herein.  Lender may, in its sole discretion, suspend or 
terminate any obligation it may have hereunder to make additional Loans or 
disbursements under existing Loans.  Lender may assume any contract of 
Borrower, and make any modifications thereto as Lender in good faith deems 
appropriate.  Lender may use any equipment, material, or supplies of Borrower, 
wherever located, that have been purchased or otherwise acquired in connection 
with the Business.  Lender may settle, defend, compromise, discharge, and 
otherwise deal with any claim arising in connection with the Business, 
including without limitation any liens pertaining thereto, upon such terms and 
conditions as Lender in good faith deems appropriate.  Borrower shall be 
liable for all costs and expenses incurred by Lender in connection with the 
foregoing or performing any duty or obligation of Borrower under this 
Agreement or the Loan Documents.  Borrower agrees to indemnify, defend and 
hold harmless Lender from any against all claims, expenses, losses, and 
liabilities incurred by Lender with respect to the exercise of any of its 
rights or remedies, except such matters arising from Lender's gross negligence 
or willful misconduct.  To the extent permitted by law, Borrower waives any 
rights to presentment, demand, protest, or notice of any kind in connection 
with this Agreement and the Note.  No failure or delay on the part of Lender 
in exercising any right, power, or privilege hereunder will preclude any other 
or further exercise thereof or the exercise of any other right, power, or 
privilege.  The rights and remedies provided herein are cumulative and not 
exclusive of any other rights or remedies provided at law or in equity.  
Borrower agrees to pay all costs of collection incurred by reason of the 
default, including court costs and reasonable attorney's fees,  including 
without limitation such expenses incurred before any legal action, 
reorganization, or bankruptcy proceeding involving Borrower has commenced, 
during the pendency of any such proceedings, and continuing to all such 
expenses in connection with any appeal to higher courts arising out of matters 
associated herewith.

     14.     Supervisory Rights and Relationship of the Parties.  Any 
supervisory rights granted to or exercised by Lender under this Agreement or 
the Loan Documents, and any opinions or recommendations made by any agent, 
inspector, or attorney for Lender, are solely for the benefit and protection 
of Lender.  Lender has no duty or obligation to Borrower, any Guarantor, or 
any other person except as expressly provided herein or in the Loan 
Documents.  Without limiting the foregoing, Lender is under no duty or 
obligation to see that any Loan proceeds are used for the purposes 
contemplated herein, to see that adequate insurance is obtained or maintained, 
to supervise the operation of the Business, or to exercise any of its rights 
or remedies hereunder or under the Loan Documents.  This Agreement and the 
Loan Documents shall be enforceable even if Lender is negligent or derelict in 
administering any Loan, perfecting or continuing the perfection of its 
security interest in any Collateral, or pursuing any right or remedy available 
to it.  The relationship of Borrower and Lender is that of a debtor and 
creditor, respectively, and Lender has no fiduciary duties to Borrower with 
respect to the Loans.  Borrower and Lender are not partners, joint ventures, 
or agents of the other with respect to the transactions contemplated hereby 
except as otherwise expressly provided herein for actions that may be taken by 
Lender on behalf of Borrower in pursuing any remedies available to it 
hereunder or under the Loan Documents.

     15.     Notice. Unless otherwise specifically provided herein, all 
notices shall be in writing addressed to the respective party as set forth 
below and may be personally served, sent by facsimile transmission, or sent by 
overnight courier service or United States mail.  Such notices shall be deemed 
to have been given:  (a) if delivered in person, when delivered; (b) if sent 
by facsimile transmission, on the date of transmission if transmitted by 4:00 
p.m. (Salt Lake City time) on a day on which Lender is generally open for 
business (a "Business Day") or, if not, on the next succeeding Business Day; 
(c) if delivered by overnight courier, two Business Days after delivery to 
such courier properly addressed;  or (d) if by United States mail, four 
Business Days after depositing in the United States mail, postage prepaid and 
properly addressed.  Notices shall be addressed as follows:

          If to Borrower:  Rockwood Companies LLC
                           11845 West Olympic Boulevard, Suite 710
                           Los Angeles, California 90064
                           Attention: Ira E. Ritter
                           Facsimile No.:  (310) 479-5902

          with a copy to:  Riordan & McKinzie
                           300 South Grand Avenue, 29th Floor
                           Los Angeles, California 90071
                           Attention:  Thomas L. Harnsberger, Esq.
                           Facsimile No.:  (213) 229-8550

          If to Lender:    Biomune Systems, Inc.
                           2401 South Foothill Drive
                           Salt Lake City, Utah 84109
                           Attention:  David G. Derrick, CEO
                           Facsimile No.:  (801) 466-3741

          with a copy to:  Durham, Evans, Jones & Pinegar
                           50 South Main Street, Suite 850
                           Salt Lake City, Utah 84144
                           Attention:  Kevin R. Pinegar, Esq.
                           Facsimile No.:  (801) 538-2425

or to such other address as the party to whom such notice is intended shall 
have previously designated by written notice to the serving party.

     16.     Termination of Line.  The Credit Line described herein shall 
terminate on the Expiration Date; subject, however, to the right of Borrower 
to renew the credit line for up to two (2) consecutive one-year terms upon 
written request to Lender not less than 30 days prior to the Expiration Date 
(or the Expiration Date of the first renewal term).  Renewal will be permitted 
provided Borrower is not then in default under any material provision of this 
Agreement.  Notwithstanding such termination, the terms of this Agreement and 
the Loan Documents shall continue in full force and effect as to all Loans 
which were approved prior to the Expiration Date and are outstanding as of the 
Expiration Date until such time as all obligations thereunder have been fully 
performed and discharged.  Without limiting the foregoing, Borrower may 
continue to receive disbursements under such Loans and shall continue to make 
payments and perform other obligations as required under the relevant Loan 
Documents.

     17.     General Provisions.  All representations and warranties made in 
this Agreement and the other Loan Documents, and in any certificate delivered 
pursuant thereto, shall survive the execution and delivery of this Agreement, 
the making of any Loan, and the repayment thereof.  This Agreement will be 
binding upon and inure to the benefit of Borrower and Lender, their respective 
successors and assigns, except that Borrower may not assign or transfer its 
rights or delegate its duties hereunder without the prior written consent of 
Lender.  This Agreement and the Loan Documents will be governed by and 
construed and interpreted in accordance with the laws of the state of Utah.  
Time is of the essence hereof.  Lender may set off against any debt or account 
it owns Borrower, now existing or hereafter arising, in accordance with its 
rules and regulations governing deposit accounts then in existence, and for 
such purposes is hereby granted a security interest in all such accounts. 

     18.     Entire Agreement.  This Agreement and the Loan Documents 
constitute the entire understanding and agreement of the parties with respect 
to the general subject matter thereof; supersede all prior negotiations, 
discussions and agreements with respect thereto; cannot be contradicted by 
evidence of any alleged oral agreement; and may not be amended, modified, or 
rescinded in any manner except by written agreement signed by the parties 
which clearly and unequivocally indicates an intent to amend, modify, or 
rescind the same.

     19.     Cross Default and Cross Collateralization.  Notwithstanding 
anything contained herein or in the Loan Documents or any other agreement 
between Borrower and Lender to the contrary, Borrower agrees: (a) that any defau
lt by Borrower with respect to this or any other agreement between Borrower 
and Lender, whether presently existing or hereafter entered into or arising, 
(collectively, "Borrower's Contracts") shall constitute a default with respect 
to all such Borrower's Contracts; and (b) any and all collateral that may now 
or hereafter secure any obligation, duty, or liability of Borrower with 
respect to any of Borrower's Contracts shall also secure all of Borrower's 
obligations, duties, and liabilities to Lender with respect to all of 
Borrower's Contracts, and Borrower hereby assigns to Lender and grants Lender 
a security interest in all such collateral for such purpose.

     20.     JURY WAIVER.  THE PARTIES HEREBY WAIVE THE RIGHT TO HAVE A JURY 
HEAR OR DETERMINE ANY DISPUTE, CLAIM, DEMAND, OR OTHER PROCEEDING ARISING IN 
ANY MANNER IN CONNECTION WITH THE LOAN DOCUMENTS OR THE MAKING OR 
ADMINISTRATION OF ANY LOAN, INCLUDING WITHOUT LIMITATION MATTERS BASED ON 
THEORIES OF CONTRACT, STATUTORY, OR TORT LAW. 
<PAGE>

     EXECUTED on the day and year first written above.

          BORROWER:           Rockwood Companies, LLC, 
                              a California limited liability company

                                   /s/ Ira E. Ritter
                              By: __________________________________
                                     Ira E. Ritter, Its President
               

          LENDER:             Biomune Systems, Inc.,
                              a Nevada corporation

                                  /s/ David G. Derrick
                              By: _______________________________________
                                        President
                              Title: ______________________________________


The following persons are designated as Authorized Persons:

     Name                                     Title                    
     __________________________________     ___________________________
     __________________________________     ___________________________

















<PAGE>
                                 EXHIBIT A
Loan Number: ____________________
Date: ___________________________

                                CLOSING ADVICE

     This Closing Advice is made in connection with a Line of Credit Agreement 
dated May 27, 1998, (the "Agreement") between Biomune Systems, Inc., as 
Lender, and Rockwood Companies, LLC, as Borrower.  Capitalized terms used 
herein and not otherwise defined shall have the meanings given in the 
Agreement.

     We are pleased to inform you that, pursuant to the terms and conditions 
of the Agreement, the following Loan has been approved:

     Loan amount:     $___________________

Interest Rate:Prime Rate plus 1% per annum.  As used herein, "Prime Rate" 
means the interest designated from time to time by Key Bank NA as its prime or 
base lending rate.  Prime Rate does not necessarily means the lowest or best 
rate at which Lender will make a loan or xtend credit.

     Loan Term:[    ]Twelve (12) months from the date hereof.

Repayment:Interest only commencing on the first day of the month following 
this Closing Advice.  The entire unpaid principal balance, together with 
accrued interest and any other unpaid charges, will be due and payable on 
_________________, 19___.

     Other Terms:     1.5% origination fee.     




Borrower:                         Lender:
Rockwood Companies, LLC     Biomune Systems, Inc.


By: ______________________________     By: __________________________________
Title: Authorized Person               Title: _______________________________
<PAGE>

                                 EXHIBIT B
                        (To Line of Credit Agreement)


$1,000,000.00                                                 May 27, 1998
                                                          Salt Lake City, Utah

                              PROMISSORY NOTE
                        (Line of Credit Agreement)

     This Promissory Note is made in connection with that Line of Credit 
Agreement dated May 27, 1998 (the "Agreement") between Biomune Systems, Inc., 
a Nevada corporation ("Lender") and Rockwood Companies, LLC, a California 
limited liability company, ("Borrower"), and is the promissory note referred 
to therein as the "Note."  All capitalized terms used in this Note that are 
not otherwise defined herein shall have the meanings given to them in the 
Agreement.  The Agreement provides, among other things, that Lender has 
established a guidance line of credit (the "Credit Line") for Borrower 
pursuant to which Lender may, from time to time, agree to make Loans for the 
purposes of funding the operations of the Business of Borrower.  In connection 
with each commitment to make a Loan, Borrower and Lender shall execute a 
Closing Advice which sets forth for such Loan, among other things, the 
principal amount committed for the Loan, the applicable interest rate, and the 
repayment terms.  All amounts advances or disbursed on the Loans are deemed 
principal advances under this Note.  The Credit Line will terminate on the 
Expiration Date; provided, however, the disbursement and repayment of 
individual Loans may extend beyond the Expiration Date, if so provided in the 
corresponding Closing Advices.

     For value received, Borrower promises to pay to Lender the principal 
amount of ONE MILLION AND NO/100 DOLLARS ($1,000,000.00), or so much thereof 
as may be advanced under the terms of this Note and the Agreement with respect 
to the Loans, together with interest on the unpaid principal balance at Prime 
Rate plus one percent (the "Effective Rate").  As used herein, "Prime Rate" 
means the interest rate designated from time to time by Key Bank NA as its 
"base" or "prime" lending rate.  The Prime Rate is an index used to calculate 
the effective interest rates for certain variable-rate loans which use that 
term as the index, and does not necessarily mean the best or lowest rate at 
which the bank is willing to make a loan or extend credit.

     Borrower agrees to make payments on each Loan as provided in the 
corresponding Closing Advice.  All payments shall be made in lawful money of 
the United States of America at Lender's offices, 2401 South Foothill Blvd., 
Salt Lake City, Utah 84109 or such other place as the holder of this Note may 
designate.  Any payment not made within ten (10) days of its scheduled payment 
date shall be subject to a late charge equal to three (3%) of the amount of 
the delinquent payment.  Any payment falling due on a Saturday, Sunday, or 
other day on which banks in the state of Utah are required or authorized to be 
closed for the general transaction of banking business shall be due on the 
next business day; provided, however, for purposes of determining late charges 
and other matters concerning or defined with respect to the delinquency of 
payments, all payments shall be considered to be due on their 
regularly-scheduled payment date.  All payments received by Lender with 
respect to or on account of each Loan shall be applied in the following 
priority: First, to all costs and reasonable expenses incurred by Lender in 
collecting the same; Second, to any late charges; Third, to accrued interest; 
and Fourth, to the reduction of principal; and Fifth, the balance, if any, to 
Borrower or such other persons entitled thereto.  Notwithstanding the 
foregoing, upon the occurrence of an Event of Default, Lender may alter the 
priority of payments set forth above and may apply any excess payments 
received on account of any Loan, after the payment of all amounts due 
thereunder, to the amounts owing on any other Loan.

     The occurrence of an Event of Default under the Agreement shall 
constitute a default under this Note.  Lender may thereafter pursue all rights 
and remedies provided in the Agreement.  In addition, upon the occurrence of 
an Event of Default and during the continuance thereof, Lender may, in its 
sole discretion, increase the margin used to calculate the Effective Rate on 
all Loans by an additional three hundred (300) basis points (i.e., by an 
additional 3%), both before and after judgment.  Reference is made to the 
Agreement for what constitutes an Event of Default and the remedies available 
thereby to Lender, all of which are incorporated herein by this reference.

     This Note is made in connection with and pursuant to the terms of the 
Agreement and is entitled to all of the benefits thereof.  This note is made 
under and will be governed in accordance with the laws of the state of Utah.

     Executed on the day and year first shown above.

                               ROCKWOOD COMPANIES, LLC,
                               a California limited liability company

                                   /s/ Ira E. Ritter
                              By: __________________________________
                                     Ira E. Ritter, Its President








     


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission